209 related articles for article (PubMed ID: 11956130)
1. Inhibition of calcineurin and sarcolemmal Ca2+ influx protects cardiac morphology and ventricular function in K(v)4.2N transgenic mice.
Sah R; Oudit GY; Nguyen TT; Lim HW; Wickenden AD; Wilson GJ; Molkentin JD; Backx PH
Circulation; 2002 Apr; 105(15):1850-6. PubMed ID: 11956130
[TBL] [Abstract][Full Text] [Related]
2. Prevention of hypertrophy by overexpression of Kv4.2 in cultured neonatal cardiomyocytes.
Zobel C; Kassiri Z; Nguyen TT; Meng Y; Backx PH
Circulation; 2002 Oct; 106(18):2385-91. PubMed ID: 12403671
[TBL] [Abstract][Full Text] [Related]
3. Reduction of I(to) causes hypertrophy in neonatal rat ventricular myocytes.
Kassiri Z; Zobel C; Nguyen TT; Molkentin JD; Backx PH
Circ Res; 2002 Mar; 90(5):578-85. PubMed ID: 11909822
[TBL] [Abstract][Full Text] [Related]
4. Targeted expression of a dominant-negative K(v)4.2 K(+) channel subunit in the mouse heart.
Wickenden AD; Lee P; Sah R; Huang Q; Fishman GI; Backx PH
Circ Res; 1999 Nov; 85(11):1067-76. PubMed ID: 10571538
[TBL] [Abstract][Full Text] [Related]
5. Sarcoplasmic reticulum adenosine triphosphatase overexpression in the L-type Ca2+ channel mouse results in cardiomyopathy and Ca2+ -induced arrhythmogenesis.
Rubio M; Bodi I; Fuller-Bicer GA; Hahn HS; Periasamy M; Schwartz A
J Cardiovasc Pharmacol Ther; 2005 Dec; 10(4):235-49. PubMed ID: 16382260
[TBL] [Abstract][Full Text] [Related]
6. Insights into cardioprotection obtained from study of cellular Ca2+ handling in myocardium of true hibernating mammals.
Yatani A; Kim SJ; Kudej RK; Wang Q; Depre C; Irie K; Kranias EG; Vatner SF; Vatner DE
Am J Physiol Heart Circ Physiol; 2004 Jun; 286(6):H2219-28. PubMed ID: 14962828
[TBL] [Abstract][Full Text] [Related]
7. Enhanced sarcolemmal Ca2+ efflux reduces sarcoplasmic reticulum Ca2+ content and systolic Ca2+ in cardiac hypertrophy.
Díaz ME; Graham HK; Trafford AW
Cardiovasc Res; 2004 Jun; 62(3):538-47. PubMed ID: 15158146
[TBL] [Abstract][Full Text] [Related]
8. PKC-alpha regulates cardiac contractility and propensity toward heart failure.
Braz JC; Gregory K; Pathak A; Zhao W; Sahin B; Klevitsky R; Kimball TF; Lorenz JN; Nairn AC; Liggett SB; Bodi I; Wang S; Schwartz A; Lakatta EG; DePaoli-Roach AA; Robbins J; Hewett TE; Bibb JA; Westfall MV; Kranias EG; Molkentin JD
Nat Med; 2004 Mar; 10(3):248-54. PubMed ID: 14966518
[TBL] [Abstract][Full Text] [Related]
9. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice.
Kadambi VJ; Ponniah S; Harrer JM; Hoit BD; Dorn GW; Walsh RA; Kranias EG
J Clin Invest; 1996 Jan; 97(2):533-9. PubMed ID: 8567978
[TBL] [Abstract][Full Text] [Related]
10. Increased SR Ca2+ cycling contributes to improved contractile performance in SERCA2a-overexpressing transgenic rats.
Maier LS; Wahl-Schott C; Horn W; Weichert S; Pagel C; Wagner S; Dybkova N; Müller OJ; Näbauer M; Franz WM; Pieske B
Cardiovasc Res; 2005 Sep; 67(4):636-46. PubMed ID: 15932750
[TBL] [Abstract][Full Text] [Related]
11. The effects of intracellular Ca2+ on cardiac K+ channel expression and activity: novel insights from genetically altered mice.
Xu Y; Zhang Z; Timofeyev V; Sharma D; Xu D; Tuteja D; Dong PH; Ahmmed GU; Ji Y; Shull GE; Periasamy M; Chiamvimonvat N
J Physiol; 2005 Feb; 562(Pt 3):745-58. PubMed ID: 15564282
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms underlying rate-dependent remodeling of transient outward potassium current in canine ventricular myocytes.
Xiao L; Coutu P; Villeneuve LR; Tadevosyan A; Maguy A; Le Bouter S; Allen BG; Nattel S
Circ Res; 2008 Sep; 103(7):733-42. PubMed ID: 18723449
[TBL] [Abstract][Full Text] [Related]
13. Ca2+-antagonists inhibit the N-methyltransferase-dependent synthesis of phosphatidylcholine in the heart.
Tappia PS; Okumura K; Kawabata K; Shah KR; Nijjar MS; Panagia V; Dhalla NS
Mol Cell Biochem; 2001 May; 221(1-2):89-98. PubMed ID: 11506191
[TBL] [Abstract][Full Text] [Related]
14. Ca2+ influx through T- and L-type Ca2+ channels have different effects on myocyte contractility and induce unique cardiac phenotypes.
Jaleel N; Nakayama H; Chen X; Kubo H; MacDonnell S; Zhang H; Berretta R; Robbins J; Cribbs L; Molkentin JD; Houser SR
Circ Res; 2008 Nov; 103(10):1109-19. PubMed ID: 18832749
[TBL] [Abstract][Full Text] [Related]
15. Relationship between K+ channel down-regulation and [Ca2+]i in rat ventricular myocytes following myocardial infarction.
Kaprielian R; Wickenden AD; Kassiri Z; Parker TG; Liu PP; Backx PH
J Physiol; 1999 May; 517 ( Pt 1)(Pt 1):229-45. PubMed ID: 10226162
[TBL] [Abstract][Full Text] [Related]
16. Ca2+ controls functional expression of the cardiac K+ transient outward current via the calcineurin pathway.
Perrier E; Perrier R; Richard S; Bénitah JP
J Biol Chem; 2004 Sep; 279(39):40634-9. PubMed ID: 15280354
[TBL] [Abstract][Full Text] [Related]
17. Enhanced myocyte contractility and Ca2+ handling in a calcineurin transgenic model of heart failure.
Chu G; Carr AN; Young KB; Lester JW; Yatani A; Sanbe A; Colbert MC; Schwartz SM; Frank KF; Lampe PD; Robbins J; Molkentin JD; Kranias EG
Cardiovasc Res; 2002 Apr; 54(1):105-16. PubMed ID: 12062367
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiological properties of neonatal mouse cardiac myocytes in primary culture.
Nuss HB; Marban E
J Physiol; 1994 Sep; 479 ( Pt 2)(Pt 2):265-79. PubMed ID: 7799226
[TBL] [Abstract][Full Text] [Related]
19. Tonic regulation of excitation-contraction coupling by basal protein kinase C activity in isolated cardiac myocytes.
Nicolás JM; Renard-Rooney DC; Thomas AP
J Mol Cell Cardiol; 1998 Dec; 30(12):2591-604. PubMed ID: 9990531
[TBL] [Abstract][Full Text] [Related]
20. Evidence for calcineurin-mediated regulation of SERCA 2a activity in human myocardium.
Münch G; Bölck B; Karczewski P; Schwinger RH
J Mol Cell Cardiol; 2002 Mar; 34(3):321-34. PubMed ID: 11945024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
